Compare FTAI & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FTAI | GEHC |
|---|---|---|
| Founded | 2011 | 1892 |
| Country | United States | United States |
| Employees | 985 | N/A |
| Industry | Misc Corporate Leasing Services | Computer Software: Prepackaged Software |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.0B | 29.1B |
| IPO Year | N/A | 2022 |
| Metric | FTAI | GEHC |
|---|---|---|
| Price | $250.17 | $63.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 13 |
| Target Price | ★ $274.67 | $88.38 |
| AVG Volume (30 Days) | 1.0M | ★ 4.6M |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.75% | 0.24% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | N/A | ★ 0.85 |
| Revenue | N/A | ★ $20,625,000,000.00 |
| Revenue This Year | $32.73 | $7.12 |
| Revenue Next Year | $51.41 | $4.45 |
| P/E Ratio | ★ $65.85 | $72.98 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $109.90 | $58.75 |
| 52 Week High | $323.51 | $89.77 |
| Indicator | FTAI | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 50.80 | 48.59 |
| Support Level | $216.34 | $60.86 |
| Resistance Level | $261.25 | $64.99 |
| Average True Range (ATR) | 13.61 | 1.72 |
| MACD | -0.10 | 0.35 |
| Stochastic Oscillator | 75.24 | 60.41 |
FTAI Aviation Ltd is an independent engine maintenance platform focused on the CFM56-5B, CFM56-7B, and V2500 aircraft engines, which power the 737NG and A320ceo aircraft. The company repairs and rebuilds engines in its maintenance facilities and with joint venture partners, and sells or leases engines through its proprietary Maintenance, Repair and Exchange (MRE) model under the Aerospace Products segment, which earns maximum revenue from North America and develops, repairs/refurbishes, and sells aircraft engines and aftermarket components. It also operates an Aviation Leasing segment, owning and managing a portfolio of on- and off-lease aircraft and engines, including engine transfers for rebuilding and sales.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).